<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="rob-ad" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">rob-ad</book-part-id>
      <title-group>
        <title>Autosomal Dominant Robinow Syndrome</title>
        <alt-title alt-title-type="alt-title">Synonym: Fetal Face Syndrome</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Roifman</surname>
            <given-names>Maian</given-names>
          </name>
          <degrees>MD</degrees>
          <email>maian.roifman@gmail.com</email>
          <aff>Division of Clinical and Metabolic Genetics<break/>Department of Paediatrics<break/>The Hospital for Sick Children<break/>Prenatal Diagnosis and Medical Genetics Program<break/>Department of Obstetrics and Gynecology<break/>Mount Sinai Hospital<break/>University of Toronto<break/>Toronto, Canada</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Brunner</surname>
            <given-names>Han</given-names>
          </name>
          <degrees>MD</degrees>
          <email>han.brunner@radboudumc.nl</email>
          <aff>Department of Human Genetics<break/>Radboud University Medical Center<break/>Nijmegen, The Netherlands</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lohr</surname>
            <given-names>Jamie</given-names>
          </name>
          <degrees>MD</degrees>
          <email>lohrx003@umn.edu</email>
          <aff>Division of Pediatric Cardiology<break/>Adult Congenital and Cardiovascular Genetics Program<break/>University of Minnesota Amplatz Children's Hospital<break/>Minneapolis, Minnesota</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mazzeu</surname>
            <given-names>Juliana</given-names>
          </name>
          <degrees>PhD</degrees>
          <email>julianamazzeu@pq.cnpq.br</email>
          <aff>Division of Clinical Medicine<break/>Faculty of Medicine<break/>University of Bras&#x000ed;lia<break/>Bras&#x000ed;lia, Brazil</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Chitayat</surname>
            <given-names>David</given-names>
          </name>
          <degrees>MD</degrees>
          <email>dchitayat@mtsinai.on.ca</email>
          <aff>Prenatal Diagnosis and Medical Genetics Program<break/>Department of Obstetrics and Gynecology<break/>Mount Sinai Hospital<break/>Division of Clinical and Metabolic Genetics<break/>Department of Paediatrics<break/>The Hospital for Sick Children<break/>University of Toronto<break/>Toronto, Canada</aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2015-01-08" date-type="created">
          <day>8</day>
          <month>1</month>
          <year>2015</year>
        </date>
        <date iso-8601-date="2015-07-30" date-type="revised">
          <day>30</day>
          <month>7</month>
          <year>2015</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="peaf" document-type="chapter">Autosomal Dominant Partial Epilepsy with Auditory Features</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="mckd1" document-type="chapter">Autosomal Dominant Tubulointerstitial Kidney Disease, <italic toggle="yes">MUC1</italic>-Related</related-object>
      <abstract id="rob-ad.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Autosomal dominant Robinow syndrome (ADRS) is characterized by skeletal findings (short stature, mesomelic limb shortening predominantly of the upper limbs, and brachydactyly); genital abnormalities (in males: micropenis/webbed penis, hypoplastic scrotum, cryptorchidism; in females: hypoplastic clitoris and labia majora); dysmorphic facial features; dental abnormalities (including malocclusion, crowding, hypodontia, late eruption of permanent teeth); bilobed tongue; occasional prenatal macrocephaly with postnatal decrease in head circumference. Less common findings include renal anomalies, radial head dislocation, vertebral abnormalities such as hemivertebrae and scoliosis, nail dysplasia, cardiac defect, cleft lip/palate, and (rarely) cognitive delay. When present, cardiac defects are a major cause of morbidity and mortality.</p>
          <p>A variant of Robinow syndrome, associated with osteosclerosis and caused by <italic toggle="yes">DVL1</italic> pathogenic variants, is characterized by normal stature, persistent macrocephaly, increased bone mineral density with skull osteosclerosis, and hearing loss, in addition to the typical features described above.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of ADRS is established in a proband with typical suggestive findings and a family history consistent with autosomal dominant inheritance. The diagnosis is supported by identification of a heterozygous <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> pathogenic variant.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Corrective surgeries as needed for cryptorchidism, abnormal penile insertion/penoscrotal position, and cleft lip/palate. Hormone therapy may be helpful for males with micropenis. Orthodontic treatment is typically required.</p>
          <p><italic toggle="yes">Surveillance:</italic> Measurement of head circumference regularly in infancy and throughout childhood. Developmental assessment every three months in infancy and every six months to one year thereafter, or more frequently as needed if cognitive delays are identified. Dental evaluation every six to 12 months or as recommended. Regular cardiac and renal assessment as needed by respective specialists if abnormalities are identified.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> Evaluation of the sibs of a proband in order to identify as early as possible those who would benefit from institution of treatment and surveillance.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Pregnancy in affected women appears to be generally uncomplicated. For an affected fetus, c&#x000e6;sarean section may be required for abnormal presentation and/or cephalopelvic disproportion.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>ADRS is inherited in an autosomal dominant manner. A proband may have the disorder as a result of either an inherited or <italic toggle="yes">de novo</italic> pathogenic variant. Each child of an individual with ADRS has a 50% chance of inheriting the pathogenic variant; however, the severity of the clinical manifestations cannot be predicted from the results of molecular genetic testing. Prenatal testing for pregnancies at increased risk is possible if the pathogenic <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> variant has been identified in an affected family member.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="rob-ad.Diagnosis">
        <title>Diagnosis</title>
        <sec id="rob-ad.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Autosomal dominant Robinow syndrome (ADRS) should be suspected in individuals with the following clinical findings [<xref ref-type="bibr" rid="rob-ad.REF.mazzeu.2007.320">Mazzeu et al 2007</xref>, <xref ref-type="bibr" rid="rob-ad.REF.person.2010.327">Person et al 2010</xref>, <xref ref-type="bibr" rid="rob-ad.REF.beiraghi.2011.15">Beiraghi et al 2011</xref>, <xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al 2015</xref>]:</p>
          <p>
            <bold>Skeletal</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Short stature</p>
            </list-item>
            <list-item>
              <p>Mesomelic limb shortening predominantly affecting the upper limbs</p>
            </list-item>
            <list-item>
              <p>Brachydactyly</p>
            </list-item>
          </list>
          <p>
            <bold>Genital</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>In males: micropenis/webbed penis, hypoplastic scrotum, cryptorchidism</p>
            </list-item>
            <list-item>
              <p>In females: hypoplastic clitoris and labia majora</p>
            </list-item>
          </list>
          <p>
            <bold>Craniofacial</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Dysmorphic facial features resembling a fetal face: widely spaced and prominent eyes, high anterior hairline, frontal bossing, depressed nasal bridge, short nose with anteverted nares, wide nasal bridge with a broad nasal tip, long philtrum, midface retrusion, and low-set ears (See <xref ref-type="fig" rid="rob-ad.F1">Figure 1</xref> and <xref ref-type="fig" rid="rob-ad.F2">Figure 2</xref>.)</p>
            </list-item>
            <list-item>
              <p>Dental malocclusion, dental crowding and hypodontia, late eruption of permanent teeth, wide retromolar ridge, alveolar ridge deformation, and bilobed tongue</p>
            </list-item>
          </list>
          <p><bold>Other features less frequently seen</bold> (&#x0003c;25% of cases) [<xref ref-type="bibr" rid="rob-ad.REF.mazzeu.2007.320">Mazzeu et al 2007</xref>, <xref ref-type="bibr" rid="rob-ad.REF.person.2010.327">Person et al 2010</xref>, <xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al 2015</xref>]:</p>
          <list list-type="bullet">
            <list-item>
              <p>Post natal decrease in head circumference</p>
            </list-item>
            <list-item>
              <p>Renal anomalies (usually hydronephrosis)</p>
            </list-item>
            <list-item>
              <p>Radial head dislocation</p>
            </list-item>
            <list-item>
              <p>Vertebral abnormalities and scoliosis</p>
            </list-item>
            <list-item>
              <p>Persistent primary teeth requiring extraction</p>
            </list-item>
            <list-item>
              <p>Nail dysplasia</p>
            </list-item>
            <list-item>
              <p>Cardiac defect</p>
            </list-item>
            <list-item>
              <p>Cleft lip/palate</p>
            </list-item>
            <list-item>
              <p>Cognitive delay</p>
            </list-item>
          </list>
        </sec>
        <sec id="rob-ad.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of autosomal dominant Robinow syndrome is established in a proband with both of the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Typical <xref ref-type="sec" rid="rob-ad.Suggestive_Findings">suggestive findings</xref></p>
            </list-item>
            <list-item>
              <p>A family history consistent with an autosomal dominant inheritance pattern, including simplex cases (a single occurrence in a family) caused by <italic toggle="yes">de novo</italic> mutation</p>
            </list-item>
          </list>
          <p>The diagnosis of ADRS is supported by an identified heterozygous <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> pathogenic variant (see <xref ref-type="table" rid="rob-ad.T.summary_of_molecular_genetic_te">Table 1</xref>).</p>
          <p>Note: If a heterozygous pathogenic variant is not identified in <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1,</italic> it is appropriate to exclude the presence of biallelic <italic toggle="yes">ROR2</italic> pathogenic variants (which cause <related-object link-type="booklink" source-id="gene" document-id="rob" document-type="chapter">autosomal recessive Robinow syndrome</related-object>).</p>
          <p>Molecular genetic testing of <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> begins with sequence analysis, followed by deletion/duplication analysis if no pathogenic variant is identified.</p>
          <table-wrap id="rob-ad.T.summary_of_molecular_genetic_te" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Autosomal Dominant Robinow Syndrome</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">WNT5A</italic>
                  </td>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">5 families&#x000a0;<sup>3</sup> / ~50 families reported (unknown number of families tested)</td>
                </tr>
                <tr>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">DVL1</italic>
                  </td>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">10 families&#x000a0;<sup>5</sup> (unknown number of families tested)</td>
                </tr>
                <tr>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>6</sup></td>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_rob-ad.T.summary_of_molecular_genetic_te_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="rob-ad.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="rob-ad" object-id="rob-ad.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="rob-ad.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants.</p>
              </fn>
              <fn id="rob-ad.TF.1.2">
                <label>2. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="rob-ad.TF.1.3">
                <label>3. </label>
                <p><xref ref-type="bibr" rid="rob-ad.REF.person.2010.327">Person et al [2010]</xref>, <xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al [2015]</xref> (see <xref ref-type="table" rid="rob-ad.T.wnt5a_selected_pathogenic_varia">Table 2</xref>)</p>
              </fn>
              <fn id="rob-ad.TF.1.4">
                <label>4. </label>
                <p>Testing that identifies exon or whole-gene deletions/duplications not detectable by sequence analysis of the coding and flanking intronic regions of genomic DNA. Included in the variety of methods that may be used are: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and chromosomal microarray (CMA) that includes this gene/chromosome segment.</p>
              </fn>
              <fn id="rob-ad.TF.1.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="rob-ad.REF.bunn.2015.623">Bunn et al [2015]</xref>, <xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al [2015]</xref></p>
              </fn>
              <fn id="rob-ad.TF.1.6">
                <label>6. </label>
                <p>Individuals with a skeletal dysplasia suggestive of ADRS with atypical features (with short-limbed dwarfism without a mesomelic pattern, with less typical facial features and/or absence of genital hypoplasia) have not been associated with <italic toggle="yes">WNT5A, DVL1</italic>, or <italic toggle="yes">ROR2</italic> pathogenic variants and, therefore, may reflect locus heterogeneity in this disorder [Authors&#x02019; personal experience].</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="rob-ad.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="rob-ad.Clinical_Description">
          <title>Clinical Description</title>
          <p><bold>Facial.</bold> Clinical features of autosomal dominant Robinow syndrome (ADRS) are noticeable at birth or in early childhood. The distinctive facial features become less apparent with age.</p>
          <p>Prominent facial features in adulthood include widely spaced eyes, wide nasal bridge, and broad nasal tip.</p>
          <p>Dental malocclusion becomes apparent in early childhood and persists into adulthood, affecting the permanent dentition as well. One case of persistent primary dentition requiring extraction at age 18 years has been reported [<xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al 2015</xref>].</p>
          <p><bold>Skeletal.</bold> Short stature is almost always present at birth and sometimes identified prenatally (on detailed fetal ultrasound) as early as 20 weeks [<xref ref-type="bibr" rid="rob-ad.REF.mazzeu.2007.320">Mazzeu et al 2007</xref>, <xref ref-type="bibr" rid="rob-ad.REF.castro.2014.297">Castro et al 2014</xref>, <xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al 2015</xref>].</p>
          <p>Short stature persists into adulthood but is typically not severe, with a final adult height either at or just below -2SD in most cases [<xref ref-type="bibr" rid="rob-ad.REF.mazzeu.2007.320">Mazzeu et al 2007</xref>, <xref ref-type="bibr" rid="rob-ad.REF.person.2010.327">Person et al 2010</xref>, <xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al 2015</xref>].</p>
          <p>Some individuals with <italic toggle="yes">DVL1</italic>-associated ADRS have a unique skeletal phenotype, exhibiting normal stature, increased bone mineral density with osteosclerosis of the skull, and macrocephaly (ranging from +2.5SD to &#x0003e;+6SD) [<xref ref-type="bibr" rid="rob-ad.REF.bunn.2015.623">Bunn et al 2015</xref>, <xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al 2015</xref>].</p>
          <p><bold>Urogenital.</bold> Hypoplastic genitalia are apparent at birth for males and females.</p>
          <p>Micropenis may be present. However, in some cases, the penis may measure normally but appear small because it is webbed/embedded in the scrotal tissue or because of the abnormal insertion of penile crura inferiorly and posteriorly onto the medial aspect of the ischial tuberosity [<xref ref-type="bibr" rid="rob-ad.REF.wilcox.1997.2312">Wilcox et al 1997</xref>]. These cases may be amenable to cosmetic reconstruction (see <xref ref-type="sec" rid="rob-ad.Management_1">Management</xref>). Of note, micropenis appears to be common in ADRS (and is a constant feature of <related-object link-type="booklink" source-id="gene" document-id="rob" document-type="chapter">autosomal recessive Robinow syndrome</related-object>). The frequency of penoscrotal transposition in ADRS is unclear at this time.</p>
          <p><bold>Puberty and fertility.</bold> To the best of the authors&#x02019; knowledge, both puberty and fertility are normal and affected females can carry pregnancies to term; delivery may need to be by c&#x000e6;sarean section due to cephalopelvic disproportion.</p>
          <p><bold>Cardiac abnormalities</bold> occur in a minority of individuals with ADRS. Cardiac defects reported in Robinow syndrome (in both dominant and recessive types) include pulmonary valve stenosis/atresia, atrial septal defect, ventricular septal defect, coarctation of the aorta, tetralogy of Fallot, and tricuspid atresia [<xref ref-type="bibr" rid="rob-ad.REF.webber.1990.519">Webber et al 1990</xref>, <xref ref-type="bibr" rid="rob-ad.REF.alata.1998.332">Al-Ata et al 1998</xref>]. When present, cardiac defects are a major cause of morbidity and mortality.</p>
          <p><bold>Hearing loss (bilateral, mixed)</bold> has been reported in some individuals with <italic toggle="yes">DVL1</italic>-associated ADRS [<xref ref-type="bibr" rid="rob-ad.REF.bunn.2015.623">Bunn et al 2015</xref>, <xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al 2015</xref>].</p>
          <p><bold>Umbilical hernia</bold> has been reported in some individuals with <italic toggle="yes">DVL1</italic>-associated ADRS [<xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al 2015</xref>].</p>
          <p><bold>Intelligence</bold> is usually normal; cognitive delay occurs in a minority of individuals with ADRS.</p>
        </sec>
        <sec id="rob-ad.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No known clear genotype-phenotype correlation exists at this time.</p>
          <p><xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al [2015]</xref> reported that the five families with <italic toggle="yes">WNT5A</italic>-associated ADRS identified to date harbor domain-specific pathogenic variants in the WNT5A protein and may represent a specific clinical phenotype with classic ADRS features (with characteristic face, short stature, mesomelic limb shortening, and genital hypoplasia).</p>
          <p><italic toggle="yes">DVL1</italic>-associated RS pathogenic variants appear to be highly specific. Thus far, all cases have been associated with frameshift variants in exon 14 likely leading to a truncated transcript that escapes nonsense-mediated decay [<xref ref-type="bibr" rid="rob-ad.REF.bunn.2015.623">Bunn et al 2015</xref>, <xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al 2015</xref>]. A gain-of-function or dominant-negative mechanism (which may explain the unique skeletal phenotype of normal stature, macrocephaly, and increased bone density) has been proposed [<xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al 2015</xref>].</p>
        </sec>
        <sec id="rob-ad.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance appears to be complete with no difference between males and females. All cases presented with features noticeable at birth or in early childhood.</p>
        </sec>
        <sec id="rob-ad.Prevalence">
          <title>Prevalence</title>
          <p>ADRS is very rare. The exact prevalence of the disorder is unknown. Fewer than 50 families with ADRS have been described in the literature; five of these families have been found to have pathogenic variants in <italic toggle="yes">WNT5A</italic> [<xref ref-type="bibr" rid="rob-ad.REF.person.2010.327">Person et al 2010</xref>, <xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al 2015</xref>]. Thus far, ten families have been reported to have pathogenic variants in <italic toggle="yes">DVL1</italic> [<xref ref-type="bibr" rid="rob-ad.REF.bunn.2015.623">Bunn et al 2015</xref>, <xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al 2015</xref>].</p>
        </sec>
      </sec>
      <sec id="rob-ad.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic>.</p>
      </sec>
      <sec id="rob-ad.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><related-object link-type="booklink" source-id="gene" document-id="rob" document-type="chapter"><bold><italic toggle="yes">ROR2</italic>-related Robinow syndrome</bold></related-object> is an autosomal recessive skeletal dysplasia caused by biallelic pathogenic variants in <italic toggle="yes">ROR2</italic>. Features similar to those of ADRS include the distinctive fetal face features, short stature, mesomelic limb shortening, and genital hypoplasia. <italic toggle="yes">ROR2</italic>-related Robinow syndrome appears to be more severe than ADRS, with renal anomalies, congenital heart defects, vertebral defects, rib fusions, scoliosis, and cognitive delay occurring more frequently than in ADRS. A distinguishing feature of <italic toggle="yes">ROR2</italic>-related Robinow syndrome is clefting of the distal phalanges, mainly of the thumbs.</p>
        <p><bold>Aarskog syndrome</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/305400">305400</ext-link>). Facial features (high anterior hairline, frontal bossing, widely spaced eyes, and anteverted nares) are similar to those of ADRS. Pulmonary valve stenosis has been reported. Genital hypoplasia in males with Aarskog syndrome is characterized by a shawl scrotum in contrast to the wider spectrum of genital hypoplasia found in ADRS. Other distinguishing features include widow&#x02019;s peak and ligamentous laxity. The vertebral abnormalities and delayed teeth eruption of ADRS are not observed in Aarskog syndrome. Typical limb abnormalities in Aarskog syndrome include brachydactyly, syndactyly, and fifth finger clinodactyly.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="gr_22q11deletion" document-type="chapter"><bold>Autosomal dominant Opitz G/BBB syndrome</bold></related-object>
<bold>(ADOS)</bold> and <related-object link-type="booklink" source-id="gene" document-id="opitz" document-type="chapter"><bold>X-linked Opitz G/BBB syndrome</bold></related-object>
<bold>(XLOS)</bold> are associated with deletion in 22q11.2 and mutation of <italic toggle="yes">MID1</italic>, respectively. Similarities with ADRS include facial features (high anterior hairline, frontal bossing, widely spaced eyes, wide nasal bridge, anteverted nares) and genitourinary abnormalities (hypospadias, cryptorchidism, hypoplastic/bifid scrotum). XLOS is also characterized by laryngotracheoesophageal defects (not found in ADRS) and brain abnormalities, developmental delay and cleft lip and/or palate (much more common in ADOS and XLOS [50% of affected individuals] than ADRS). ADOS and XLOS are not usually associated with short stature or mesomelic limb shortening.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="achondroplasia" document-type="chapter"><bold>Achondroplasia</bold></related-object> is an autosomal dominant disorder caused by mutation of <italic toggle="yes">FGFR3</italic>. Facial features characteristic of achondroplasia are similar to those of ADRS (macrocephaly, high anterior hairline and frontal bossing, depressed nasal bridge, pointed nose, and midface retrusion). Unlike ADRS, the head circumference of individuals with achondroplasia is larger with continued macrocephaly throughout life and an increased incidence of hydrocephalus. Distinctive skeletal features in achondroplasia include trident appearance of the fingers, lumbar gibbus and hypotonia in infancy, hyperlordosis, bowing of the legs later in childhood, and more severe shortening of all long bones. Widely spaced eyes are not a feature of achondroplasia.</p>
        <p><bold>Omodysplasia type 2</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/164745">164745</ext-link>) is a rare autosomal dominant disorder characterized by skeletal findings, hypoplastic male genitalia (including micropenis, hypospadias, and cryptorchidism), and dysmorphic facial features. Distinct features include normal stature, rhizomelic upper limb shortening, shortened first metacarpals, and shortened humeri with hypoplastic condyles. The legs are normal. Facial features include frontal bossing, depressed nasal bridge with bifid nasal tip, and a long philtrum. Individuals with omodysplasia type 2 do not have widely spaced eyes.</p>
      </sec>
      <sec id="rob-ad.Management_1">
        <title>Management</title>
        <sec id="rob-ad.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with autosomal dominant Robinow syndrome (ADRS), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Radiographs of the limbs, chest, vertebrae and skull to establish the extent of skeletal involvement</p>
            </list-item>
            <list-item>
              <p>Assessment for possible abnormal penile insertion/penoscrotal position for consideration of reconstructive surgery</p>
            </list-item>
            <list-item>
              <p>Assessment for possible cryptorchidism</p>
            </list-item>
            <list-item>
              <p>Clinical assessment for presence of cleft lip/palate and the need for surgical repair</p>
            </list-item>
            <list-item>
              <p>Abdominal ultrasound examination for investigation of renal anomalies</p>
            </list-item>
            <list-item>
              <p>Echocardiogram to evaluate for a cardiac defect</p>
            </list-item>
            <list-item>
              <p>Endocrine consultation to assess the possibility of hormone therapy in the treatment of males with micropenis</p>
            </list-item>
            <list-item>
              <p>Urology consultation in males with cryptorchidism and abnormal penile insertion/penoscrotal transposition for consideration of reconstructive surgery</p>
            </list-item>
            <list-item>
              <p>Orthodontics consultation as needed for misaligned teeth or persistent primary dentition</p>
            </list-item>
            <list-item>
              <p>Hearing assessment</p>
            </list-item>
            <list-item>
              <p>Formal cognitive assessment if developmental delay is present</p>
            </list-item>
            <list-item>
              <p>Medical genetics consultation</p>
            </list-item>
          </list>
        </sec>
        <sec id="rob-ad.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Corrective surgeries may be required for repair of:</p>
          <list list-type="bullet">
            <list-item>
              <p>Cryptorchidism</p>
            </list-item>
            <list-item>
              <p>Abnormal penile insertion/penoscrotal position</p>
            </list-item>
            <list-item>
              <p>Cleft lip/palate</p>
            </list-item>
          </list>
          <p>Hormone therapy may be helpful for males with micropenis. Injection of human chorionic gonadotropin and testosterone improved penile length and testicular volume in three boys with severe micropenis [<xref ref-type="bibr" rid="rob-ad.REF.soliman.1998.1337">Soliman et al 1998</xref>]. Hormone therapy should be initiated and monitored by a pediatric endocrinologist.</p>
          <p>Orthodontic treatment is typically required.</p>
        </sec>
        <sec id="rob-ad.Surveillance">
          <title>Surveillance</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Head circumference measurements every three months in infancy and every six months to one year thereafter</p>
            </list-item>
            <list-item>
              <p>Developmental assessment every three months in infancy and every six months to one year thereafter, or more frequently as needed if delays identified</p>
            </list-item>
            <list-item>
              <p>Dental evaluation every six months to one year or as recommended by the dental professional on initial assessment</p>
            </list-item>
            <list-item>
              <p>Regular cardiac and renal assessment by respective specialists as needed if abnormalities are identified</p>
            </list-item>
          </list>
        </sec>
        <sec id="rob-ad.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate the sibs of a proband in order to identify as early as possible those who would benefit from institution of treatment and surveillance. If the <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> pathogenic variant in the family is known, molecular genetic testing can be used to clarify the genetic status of at-risk sibs.</p>
          <p>See <xref ref-type="sec" rid="rob-ad.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="rob-ad.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Pregnancy in affected women appears to be generally uncomplicated. For an affected fetus, c&#x000e6;sarean section may be required for abnormal presentation and/or cephalopelvic disproportion. Breech presentation requiring c&#x000e6;sarean section has been reported in one case of ADRS [<xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al 2015</xref>].</p>
        </sec>
        <sec id="rob-ad.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="rob-ad.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="rob-ad.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Autosomal dominant Robinow syndrome (ADRS) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="rob-ad.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with ADRS have an affected parent.</p>
            </list-item>
            <list-item>
              <p>The family history may appear to be negative because of failure to recognize the disorder in family members.</p>
            </list-item>
            <list-item>
              <p>A proband with ADRS may have the disorder as a result of <italic toggle="yes">de novo</italic> mutation.</p>
              <list list-type="bullet">
                <list-item>
                  <p>When neither parent has the pathogenic variant identified in the proband and/or clinical evidence of the disorder, the mutation likely occurred <italic toggle="yes">de novo</italic>.</p>
                </list-item>
                <list-item>
                  <p>Recommendations for the evaluation of parents of a proband with apparent <italic toggle="yes">de novo</italic> mutation of <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> include complete physical examination for associated clinical features and testing for the pathogenic variant identified in the proband. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Alternatively, if the <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, a proband with ADRS may have the disorder as a result of germline mosaicism in one of the parents. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
          </list>
          <p>Note: If the parent is the individual in whom the pathogenic variant first occurred s/he may have somatic mosaicism for the variant and may be mildly/minimally affected.</p>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%. However, the severity of the clinical manifestations cannot be predicted from the results of molecular genetic testing.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is low but greater than that of the general population because of the possibility of germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with ADRS has a 50% chance of inheriting the pathogenic variant. However, the severity of the clinical manifestations cannot be predicted from the results of molecular genetic testing.</p>
          <p>
            <bold>Other family members</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected, his or her family members may be at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="rob-ad.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="rob-ad.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has clinical evidence of the disorder, the mutation likely occurred <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="rob-ad.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p><bold>Molecular genetic testing</bold>. If the <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing for the gene of interest or custom prenatal testing. However, the severity of clinical manifestations cannot be predicted from the results of molecular genetic testing.</p>
          <p><bold>Fetal ultrasound evaluation</bold>. Short long bones (measuring -2SD) as well as mesomelic shortening and macrocephaly can be detected by fetal ultrasound evaluation at approximately 20 weeks&#x02019; gestation [<xref ref-type="bibr" rid="rob-ad.REF.castro.2014.297">Castro et al 2014</xref>, <xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al 2015</xref>].</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the <italic toggle="yes">WNT5A</italic> or <italic toggle="yes">DVL1</italic> pathogenic variant has been identified.</p>
        </sec>
      </sec>
      <sec id="rob-ad.Resources">
        <title>Resources</title>
      </sec>
      <sec id="rob-ad.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="rob-ad.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <sec id="rob-ad.WNT5A">
            <title>
              <italic toggle="yes">WNT5A</italic>
            </title>
            <p>WNT5A is a member of the Wnt family of proteins, which regulate critical morphogenic events, including embryonic patterning, and cell differentiation, growth, and migration. WNT5A is critical for developmental processes requiring cell migration [reviewed in <xref ref-type="bibr" rid="rob-ad.REF.nishita.2010.346">Nishita et al 2010</xref>].</p>
            <p>WNT5A is a known co-receptor of the orphan tyrosine kinase receptor, ROR2 [<xref ref-type="bibr" rid="rob-ad.REF.oishi.2003.645">Oishi et al 2003</xref>, <xref ref-type="bibr" rid="rob-ad.REF.mikels.2006.e115">Mikels &#x00026; Nusse 2006</xref>, <xref ref-type="bibr" rid="rob-ad.REF.schambony.2007.779">Schambony &#x00026; Wedlich 2007</xref>], which would explain the overlap in clinical phenotype of <italic toggle="yes">WNT5A</italic>- and <related-object link-type="booklink" source-id="gene" document-id="rob" document-type="chapter"><italic toggle="yes">ROR2-</italic>associated Robinow syndrome</related-object>. <italic toggle="yes">WNT5A</italic> signaling gradient in the limb bud has been shown to control limb elongation [<xref ref-type="bibr" rid="rob-ad.REF.gao.2011.163">Gao et al 2011</xref>]. The murine ortholog of WNT5A was also shown to control several steps in gonadal development of mice models [<xref ref-type="bibr" rid="rob-ad.REF.tevosian.2012.1">Tevosian 2012</xref>]</p>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">WNT5A</italic> comprises five exons. Alternate splicing results in multiple transcript variants. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="rob-ad" object-id="rob-ad.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
            <p><bold>Pathogenic allelic variants.</bold>
<xref ref-type="table" rid="rob-ad.T.wnt5a_selected_pathogenic_varia">Table 2</xref> lists the pathogenic variants identified in five families with autosomal dominant Robinow syndrome [<xref ref-type="bibr" rid="rob-ad.REF.person.2010.327">Person et al 2010</xref>, <xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al 2015</xref>].</p>
            <table-wrap id="rob-ad.T.wnt5a_selected_pathogenic_varia" position="anchor" orientation="portrait">
              <label>Table 2. </label>
              <caption>
                <p><italic toggle="yes">WNT5A</italic> Selected Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change<break/>(Alias&#x000a0;<sup>1</sup>)</th>
                    <th id="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.257A&#x0003e;G&#x000a0;<sup>2</sup></td>
                    <td headers="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Tyr86Cys</td>
                    <td headers="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_3" rowspan="4" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_003392.4">NM_003392.4</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_003383.2">NP_003383.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.206G&#x0003e;A</td>
                    <td headers="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys69Tyr</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.248G&#x0003e;C</td>
                    <td headers="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys83Ser</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.544_545delinsTC<break/>(544&#x02013;545CT&#x0003e;TC)</td>
                    <td headers="hd_h_rob-ad.T.wnt5a_selected_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Cys182Ser<break/>(Cys182Arg)</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
                <fn id="rob-ad.TF.2.1">
                  <label>1. </label>
                  <p>Variant designation that does not conform to current naming conventions</p>
                </fn>
                <fn id="rob-ad.TF.2.2">
                  <label>2. </label>
                  <p>Two families had this variant.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> WNT5A is critical for developmental processes requiring cell migration [reviewed in <xref ref-type="bibr" rid="rob-ad.REF.nishita.2010.346">Nishita et al 2010</xref>]. The three-dimensional structure of the WNT5A protein is still unknown.</p>
            <p><bold>Abnormal gene product.</bold> Based on a WNT5A homology model using the experimentally solved structure of WNT8, <xref ref-type="bibr" rid="rob-ad.REF.roifman.2015.34">Roifman et al [2015]</xref> showed that pathogenic variants found in all individuals with <italic toggle="yes">WNT5A</italic>-associated ADRS seem to be located on one side of the protein and may affect interactions with other proteins in the Wnt pathway by disrupting normal complex formation and/or intra-protein bonds.</p>
          </sec>
          <sec id="rob-ad.DVL1">
            <title>
              <italic toggle="yes">DVL1</italic>
            </title>
            <p><italic toggle="yes">DVL1</italic> encodes segment polarity protein dishevelled homolog DVL-1 (DVL1), an essential downstream mediator of Wnt signaling, specifically the Wnt5a-ROR2 non-canonical pathway [<xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al 2015</xref>].</p>
            <p><bold>Gene structure.</bold>
<italic toggle="yes">DVL1</italic> comprises 15 exons.</p>
            <p><bold>Pathogenic allelic variants.</bold> See <xref ref-type="table" rid="rob-ad.T.dvl1_selected_pathogenic_varian">Table 3</xref>.</p>
            <table-wrap id="rob-ad.T.dvl1_selected_pathogenic_varian" position="anchor" orientation="portrait">
              <label>Table 3. </label>
              <caption>
                <p><italic toggle="yes">DVL1</italic> Selected Pathogenic Variants</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                    <th id="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Protein Amino Acid Change</th>
                    <th id="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1570_1571delinsC</td>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Phe524ProfsTer125</td>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_3" rowspan="8" valign="middle" align="left" colspan="1">
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_004421.2">NM_004421.2</ext-link>
                      <break/>
                      <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_004412.2">NP_004412.2</ext-link>
                    </td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1505_1517del</td>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His502ProfsTer143</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1519del</td>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">pTrp507GlyfsTer142</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1508del</td>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro503ArgfsTer146</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1615del</td>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ser539AlafsTer110</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1529del</td>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly510ValfsTer139</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1562del</td>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro521HisfsTer128</td>
                  </tr>
                  <tr>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1576_1583delinsG</td>
                    <td headers="hd_h_rob-ad.T.dvl1_selected_pathogenic_varian_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Pro526AlafsTer121</td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn>
                  <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
                </fn>
                <fn>
                  <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
            <p><bold>Normal gene product.</bold> DVL1 is a member of the disheveled family of intracellular scaffolding proteins, located downstream of the Wnt receptor. DVL1 plays a role in transducing both canonical and non-canonical Wnt signaling (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/601365">601365</ext-link>).</p>
            <p><bold>Abnormal gene product.</bold> All reported pathogenic variants in <italic toggle="yes">DVL1</italic>-associated RS have been frameshift variants within exon 14, likely leading to a truncated transcript that escapes nonsense mediated decay [<xref ref-type="bibr" rid="rob-ad.REF.bunn.2015.623">Bunn et al 2015</xref>, <xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al 2015</xref>]. The resultant abnormal gene product is thought to impair Wnt signaling via a gain-of-function or dominant-negative mechanism [<xref ref-type="bibr" rid="rob-ad.REF.white.2015.612">White et al 2015</xref>].</p>
          </sec>
        </sec>
      </sec>
      <sec id="rob-ad.References">
        <title>References</title>
        <sec id="rob-ad.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="rob-ad.Literature_Cited.reflist0">
            <ref id="rob-ad.REF.alata.1998.332">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Al-Ata</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paquet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teebi</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <article-title>Congenital heart disease in Robinow syndrome.</article-title>
                <source>Am J Med Genet.</source>
                <year>1998</year>
                <volume>77</volume>
                <fpage>332</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">9600746</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.beiraghi.2011.15">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Beiraghi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leon-Salazar</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larson</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cunningham</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petryk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohr</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>Craniofacial and intraoral phenotype of Robinow syndrome forms.</article-title>
                <source>Clin Genet.</source>
                <year>2011</year>
                <volume>80</volume>
                <fpage>15</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">21496006</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.bunn.2015.623">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bunn</surname>
                    <given-names>KJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Daniel</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosken</surname>
                    <given-names>HS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>O&#x02019;Neill</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cameron-Christie</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morgan</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunst</surname>
                    <given-names>HPM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markie</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>SP</given-names>
                  </name>
                </person-group>
                <article-title>Mutations in DVL1 cause an osteosclerotic form of Robinow Syndrome.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2015</year>
                <volume>96</volume>
                <fpage>623</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">25817014</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.castro.2014.297">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Castro</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peraza</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barraza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zapata</surname>
                    <given-names>M.</given-names>
                  </name>
                </person-group>
                <article-title>Prenatal diagnosis of Robinow syndrome: a case report.</article-title>
                <source>J Clin Ultrasound.</source>
                <year>2014</year>
                <volume>42</volume>
                <fpage>297</fpage>
                <lpage>300</lpage>
                <pub-id pub-id-type="pmid">24151023</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.gao.2011.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gao</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bishop</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elliot</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garrett</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>English</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andre</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinson</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sood</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Economides</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>Wnt signaling gradients establish planar cell polarity by inducing Vangl2 phosphorylation through Ror2.</article-title>
                <source>Dev Cell.</source>
                <year>2011</year>
                <volume>20</volume>
                <fpage>163</fpage>
                <lpage>76</lpage>
                <pub-id pub-id-type="pmid">21316585</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.mazzeu.2007.320">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mazzeu</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pardono</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vianna-Morgante</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richieri-Costa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ae Kim</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunoni</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martelli</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Andrade</surname>
                    <given-names>CE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colin</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otto</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <article-title>Clinical characterization of autosomal dominant and recessive variants of Robinow syndrome.</article-title>
                <source>Am J Med Genet A.</source>
                <year>2007</year>
                <volume>143</volume>
                <fpage>320</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17256787</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.mikels.2006.e115">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mikels</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nusse</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <article-title>Purified Wnt5a protein activates or inhibits beta-catenin-TCF signaling depending on receptor context.</article-title>
                <source>PLoS Biol.</source>
                <year>2006</year>
                <volume>4</volume>
                <fpage>e115</fpage>
                <pub-id pub-id-type="pmid">16602827</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.nishita.2010.346">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nishita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Enomoto</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamagata</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>Y.</given-names>
                  </name>
                </person-group>
                <article-title>Cell/tissue-tropic functions of Wnt5a signaling in normal and cancer cells.</article-title>
                <source>Trends Cell Biol.</source>
                <year>2010</year>
                <volume>20</volume>
                <fpage>346</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">20359892</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.oishi.2003.645">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Oishi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onishi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ohkawara</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koshida</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suzuki</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamada</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwabe</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mundlos</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shibuya</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Minami</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <article-title>The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway.</article-title>
                <source>Genes Cells.</source>
                <year>2003</year>
                <volume>8</volume>
                <fpage>645</fpage>
                <lpage>54</lpage>
                <pub-id pub-id-type="pmid">12839624</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.person.2010.327">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Person</surname>
                    <given-names>AD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beiraghi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sieben</surname>
                    <given-names>CM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hermanson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neumann</surname>
                    <given-names>AN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robu</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schleiffarth</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Billington</surname>
                    <given-names>CJ</given-names>
                    <suffix>Jr</suffix>
                  </name>
                  <name name-style="western">
                    <surname>van Bokhoven</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoogeboom</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzeu</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Petryk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimmenti</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brunner</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ekker</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohr</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <article-title>WNT5A mutations in patients with autosomal dominant Robinow syndrome.</article-title>
                <source>Dev Dyn.</source>
                <year>2010</year>
                <volume>239</volume>
                <fpage>327</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">19918918</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.roifman.2015.34">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roifman</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcelis</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paton</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marshall</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silver</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lohr</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yntema</surname>
                    <given-names>HG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Venselaar</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bon</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seaward</surname>
                    <given-names>G</given-names>
                  </name>
                  <collab>FORGE Canada Consortium</collab>
                </person-group>
                <article-title>Brunner HG, Chitayat D. De novo WNT5A-associated autosomal dominant Robinow syndrome suggests specificity of genotype and phenotype.</article-title>
                <source>Clin Genet.</source>
                <year>2015</year>
                <volume>87</volume>
                <fpage>34</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">24716670</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.schambony.2007.779">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Schambony</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wedlich</surname>
                    <given-names>D.</given-names>
                  </name>
                </person-group>
                <article-title>Wnt-5A/Ror2 regulate expression of XPAPC through an alternative noncanonical signaling pathway.</article-title>
                <source>Dev Cell.</source>
                <year>2007</year>
                <volume>12</volume>
                <fpage>779</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">17488628</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.soliman.1998.1337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Soliman</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rajab</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alsalmi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bedair</surname>
                    <given-names>SM</given-names>
                  </name>
                </person-group>
                <article-title>Recessive Robinow syndrome: with emphasis on endocrine functions.</article-title>
                <source>Metabolism.</source>
                <year>1998</year>
                <volume>47</volume>
                <fpage>1337</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">9826209</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.tevosian.2012.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tevosian</surname>
                    <given-names>SG</given-names>
                  </name>
                </person-group>
                <article-title>Gone without the WNT: a requirement for WNT5A in germ cell migration and testis development.</article-title>
                <source>Biol Reprod.</source>
                <year>2012</year>
                <volume>86</volume>
                <fpage>1</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">21957192</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.webber.1990.519">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Webber</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wargowski</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chitayat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sandor</surname>
                    <given-names>GG</given-names>
                  </name>
                </person-group>
                <article-title>Congenital heart disease and Robinow syndrome: coincidence or an additional component of the syndrome?</article-title>
                <source>Am J Med Genet.</source>
                <year>1990</year>
                <volume>37</volume>
                <fpage>519</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">2260599</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.white.2015.612">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzeu</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoischen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jhangiani</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gambin</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calijorne Alcino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Penney</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saraiva</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hove</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skovby</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Estrella</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vulto-van Silfhout</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steehouwer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muzny</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sutton</surname>
                    <given-names>VR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gibbs</surname>
                    <given-names>RA</given-names>
                  </name>
                </person-group>
                <article-title>Baylor-Hopkins Center for Mendelian Genomics, Lupski JR, Brunner HG, van Bon BWM, Carvalho CMB. CVL1 frameshift mutations clustering in the penultimate exon cause autosomal-dominant Robinow syndrome.</article-title>
                <source>Am J Hum Genet.</source>
                <year>2015</year>
                <volume>96</volume>
                <fpage>612</fpage>
                <lpage>22</lpage>
                <pub-id pub-id-type="pmid">25817016</pub-id>
              </element-citation>
            </ref>
            <ref id="rob-ad.REF.wilcox.1997.2312">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>DT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quinn</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ng</surname>
                    <given-names>CS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dicks-Mireaux</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mouriquand</surname>
                    <given-names>PD</given-names>
                  </name>
                </person-group>
                <article-title>Redefining the genital abnormality in the Robinow syndrome. -004.</article-title>
                <source>J Urol.</source>
                <year>1997</year>
                <volume>157</volume>
                <fpage>2312</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">9146662</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="rob-ad.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="rob-ad.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>30 July 2015 (aa) Revision: <italic toggle="yes">DVL1</italic> and related citations added</p>
            </list-item>
            <list-item>
              <p>8 January 2015 (me) Review posted live</p>
            </list-item>
            <list-item>
              <p>18 June 2014 (mr) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="rob-ad.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>A mother and son, both affected with <italic toggle="yes">WNT5A</italic>-associated autosomal dominant Robinow syndromeA. Affected mother in infancyB, C. Affected son at birthD. Mother (age 39 years) and son (age 2 years)E. Son at age 3 yearsNote the widely spaced and prominent eyes, high anterior hairline, frontal bossing, depressed nasal bridge, short nose with anteverted nares, wide nasal bridge with a broad nasal tip, long philtrum, midface retrusion, low-set ears, and limb shortening predominantly affecting the upper limbs.</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="rob-ad-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="rob-ad.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>A boy with <italic toggle="yes">WNT5A</italic>-associated autosomal dominant Robinow syndrome at different ages. Note the widely spaced and prominent eyes, high anterior hairline, frontal bossing, depressed nasal bridge, short nose with anteverted nares, wide nasal bridge with a broad nasal tip, long philtrum, low-set ears (A, B, D, E, F), genital hypoplasia (C) and limb shortening predominantly affecting the upper limbs (D).</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="rob-ad-Image002" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
